Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • Support on the Diabetes Journey
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
Nutrisystem.com
Latest
Popular
Top Rated
Research Archives
Print | Email | Share | Comments (0)

Powerful Imaging Technology Helps to Uncover Important Interaction Involved in Tolerance

Nov 17, 2009

This press release is an announcement submitted by UCSF Diabetes Center, and was not written by Diabetes Health.

Using laser-scanning microscopy to understand immune cell actions in diabetes.

The body's immune system is supposed to "tolerate" itself and distinguish "self" from "non-self."  Autoimmune diseases such as type 1 diabetes result from the breakdown of this system, causing immune cells to attack and destroy insulin-producing beta cells or "self."  In the November issue of Nature Immunology, Brian Fife, PhD and collaborators including senior author Jeffrey Bluestone, PhD share how they have uncovered a basic process that helps control immune cell activation and tolerance. 

By utilizing two-photon laser-scanner microscopy to look at individual immune cells in a mouse model of type 1 diabetes, they discovered that when a molecule found on the immune cell called Programmed death 1 (PD-1) binds to another molecule found on another cell, PD-L1, the cells are prevented from forming stable interactions and have increased movement.  These fast-moving cells interact less with the cells in the pancreas, thereby preventing type 1 diabetes.  

The team hopes that this research will help in the development of a new generation of tolerogenic drugs that will "turn off" selected parts of the immune system, leaving the disease-fighting capabilities intact.   A UCSF postdoctoral fellow for six years, Dr. Fife is now a faculty member with the University of Minnesota's Center for Immunology. 

* * *

Nature Immunology

UCSF Diabetes Center e-Update


Categories: Diabetes, Insulin, Research, Type 1 Issues



You May Also Be Interested In...


Click Here To View Or Post Comments

Comments 0 comments - Nov 17, 2009

©1991-2012 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.